Acorah Software Products - Accounts Production 16.2.850 false true false true No description of principal activity 12 October 2023 31 October 2024 31 October 2024 15207765 Mr Michal Smolski Mrs Katie Smolski iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15207765 2023-10-11 15207765 2024-10-31 15207765 2023-10-12 2024-10-31 15207765 frs-core:CurrentFinancialInstruments 2024-10-31 15207765 frs-bus:PrivateLimitedCompanyLtd 2023-10-12 2024-10-31 15207765 frs-bus:FilletedAccounts 2023-10-12 2024-10-31 15207765 frs-bus:Micro-entities 2023-10-12 2024-10-31 15207765 frs-bus:AuditExempt-NoAccountantsReport 2023-10-12 2024-10-31 15207765 frs-bus:Director1 2023-10-12 2024-10-31 15207765 frs-bus:Director2 2023-10-12 2024-10-31
Registered number: 15207765
Smolski Medical Services Ltd
Unaudited Financial Statements
For the Period 12 October 2023 to 31 October 2024
Balance Sheet
Registered number: 15207765
31 October 2024
£
Fixed assets 743
Current assets 22,377
Creditors: Amounts Falling Due Within One Year (5,108 )
NET CURRENT ASSETS 17,269
TOTAL ASSETS LESS CURRENT LIABILITIES 18,012
Accruals and deferred income (1,440 )
NET ASSETS 16,572
CAPITAL AND RESERVES 16,572

Notes

1. General Information
Smolski Medical Services Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15207765 . The registered office is Soloman House, Caxton Road, Preston, PR2 9PL.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
Page 0
Page 1
For the period ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Michal Smolski
Director
20/02/2025